Transforming into a sustainable European pharmaceutical sector

01 June 2022 → 31 May 2026
European funding: framework programme
Research disciplines
  • Engineering and technology
    • Sustainable and environmental engineering not elsewhere classified
Other information
Project description

Pharmaceuticals comprise a wide variety of chemical compounds designed to guarantee safe and effective therapies. The active pharmaceutical ingredients (APIs) are those that deliver the beneficial health effects experienced by patients. The goal of the EU-funded TransPharm project is to develop more sustainable and greener APIs that simultaneously reduce the environmental footprint and the dependence on third countries for API production. TransPharm will deliver digital tools and guidelines based on artificial intelligence for the development of greener pharmaceutical products and APIs, as well as models to judge their impact. The result will be a more independent and competitive European pharmaceutical industry, which can ensure the timely delivery of sustainable and green therapeutics to its citizens.

Role of Ghent University
Ghent University coordinates the project and will be involved in all the work packages of the project.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the authority can be held responsible for them.